APA (7th ed.) Citation

P, S., S, D., L, R., OC, R., A, S., YC, L., . . . C, A. (2012). Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell cycle (Georgetown, Tex.), 11(20), 3801. https://doi.org/10.4161/cc.21988

Chicago Style (17th ed.) Citation

P, Sirajuddin, et al. "Quantifying the CDK Inhibitor VMY-1-103's Activity and Tissue Levels in an in Vivo Tumor Model by LC-MS/MS and by MRI." Cell Cycle (Georgetown, Tex.) 11, no. 20 (2012): 3801. https://doi.org/10.4161/cc.21988.

MLA (9th ed.) Citation

P, Sirajuddin, et al. "Quantifying the CDK Inhibitor VMY-1-103's Activity and Tissue Levels in an in Vivo Tumor Model by LC-MS/MS and by MRI." Cell Cycle (Georgetown, Tex.), vol. 11, no. 20, 2012, p. 3801, https://doi.org/10.4161/cc.21988.